Latest news
Despite Progress in TNBC, More Biomarkers Are Needed to Improve Outcomes - MedPage TodayMedPage Today · Mon, 10 Aug 2026 15:08:50 GMTFDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer - The American Journal of Managed CareThe American Journal of Managed Care · Sun, 09 Aug 2026 16:00:00 GMTOutcomes in Early-Stage Triple-Negative Breast Cancer With Dose-Dense Doxorubicin and Cyclophosphamide as Part of Pembrolizumab-Based Regimens - Journal of Hematology Oncology PharmacyJournal of Hematology Oncology Pharmacy · Fri, 07 Aug 2026 16:18:45 GMTHow Remote Therapeutic Monitoring Enhances Supportive Cancer Care - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 22:07:15 GMTClinical Data-Matched Patient Organoids Customize Drug-Resistant TNBC Treatment - Inside Precision MedicineInside Precision Medicine · Thu, 06 Aug 2026 15:00:15 GMTReal-World Patterns of Systemic Therapy Attrition Highlight Gaps in TNBC Care - Cancer Nursing TodayCancer Nursing Today · Tue, 04 Aug 2026 21:57:06 GMTDato-DXd vs Chemotherapy: What Does TROPION-Breast02 Mean for Practice? - Docwire NewsDocwire News · Tue, 04 Aug 2026 15:00:11 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer HealthCancer Health · Mon, 03 Aug 2026 13:01:12 GMT